ArticleClinical and translational radiation oncology2024

The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer.

Amelia Barcellini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.